The history of immunizing with embryonic materials to generate an antitumor immune
response dates back to a century ago. The premise is that cancer cells share the expression …

Over a century ago, it was reported that immunization with embryonic/fetal tissue could lead
to the rejection of transplanted tumors in animals. Subsequent studies demonstrated that …

Cancer cells and embryonic tissues share a number of cellular and molecular properties,
suggesting that induced pluripotent stem cells (iPSCs) may be harnessed to elicit anti-tumor …

Cancer is maintained by the activity of a rare population of self-renewing “cancer stem
cells”(CSCs), which are resistant to conventional therapies. CSCs over-express several …

Induced pluripotent stem cells (iPSCs) and cancer cells share cellular similarities and
transcriptomic profiles. Here, we show that an iPSC-based cancer vaccine, comprised of …

Significant efficacy of induced pluripotent stem cells (iPSCs) in generating DCs for cancer
vaccine therapy was suggested in our previous studies. In clinical application of DC vaccine …

Abstract Introduction Pluripotent stem cells (PSCs) are promising tools for modern
regenerative medicine applications because of their stemness properties, which include …

Induced pluripotent stem cells (iPSCs) are mainly characterized by their unlimited
proliferation abilities and potential to develop into almost any cell type. The creation of this …

Human embryonic stem cells (hESCs), initially thought to be immune privileged cells, are
now known to be susceptible to immune recognition. Human induced pluripotent stem cells …

Induced pluripotent stem cells (iPSCs), reprogrammed from somatic cells with defined
factors, hold great promise for regenerative medicine as the renewable source of autologous …